О. I. Evsyukova
Russian Cancer Research Center NN Blokhin · 12 works · 17 citations · h-index 3
Top works
- Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational study ROSLERCM
- Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study
- Renal cell carcinoma: what’s new in 2019
- International experience of using olaparib for metastatic castration-resistant prostate cancer: literature review
- Lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: an initial Russian experience
- Efficacy and safety of cabozantinib in metastatic renal cell carcinoma patients: Russian multicenter observational study
- Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study
- Безопасность спасительной цистэктомии после неудачи органосохраняющего лечения больных мышечно-инвазивным раком мочевого пузыря
- Can we rely on 18F-choline PET-CT in detection of lymphogenous metastases in prostate cancer patients with biochemical recurrence after radical treatment?
- Short-term results of salvage lymphadenectomy with lymphogenous progression of prostate cancer after radical treatment
- Первый опыт применения комбинации ленватиниба и эверолимуса при распространенном почечно-клеточном раке, резистентном к антиангиогенной терапии, в широкой клинической практике России